Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study.

Nutrients · 2018 · PMC6115941 · PMID 30126153

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0640

boldest claim

The sentences

almost significantp = 0.055so close (0.05 < p ≤ 0.1)

When Product B was analysed by dosage, there was an almost significant increase post-supplementation for the 600 mg dose ( p = 0.055), while there was no significant difference at 200 mg, or for either dose of Product A ( Table 2 ). 3.3.2.

also in 1,858 other papers

a trend toward significancep = 0.064so close (0.05 < p ≤ 0.1)

There was a trend toward significance for the increase in bLF in faeces using Product B ( p = 0.064).

also in 3,729 other papers

did not reach statistical significanceno p-value reported

Faecal Samples Levels of both hLF and bLF in faeces were higher post supplementation in the Product B (Inferrin TM ) group, but lower in the Product A (standard bLF) group, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.